ClinicalTrials.gov
public full text
Public Domain
Biomarker Study for Alzheimer's Disease
The study aims to identify immune biomarkers in peripheral blood for identifying Alzheimer's disease (AD). Blood samples from subjects with AD will be compared to age-matched controls without cognitive symptoms, as well as healthy younger subjects.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Health-related factors and their impact on blood-based biomarkers of Alzheimer's disease / Carolin Kurz, Marleen Taute, Paulina Tegethoff, Anna Hufnagel, Sophia Leonhardt, Selim Üstün Gürsel, Carolin Koriath, Alexander Jethwa, Gwendlyn Kollmorgen, Tobias Bittner, Daniel Keeser, Matthias Brendel, Jan Haeckert, Julia Utecht, Boris Papazov, Johannes Levin, Günter Höglinger, Boris-Stephan Rauchmann, Robert Perneczky#783922
- Blood-based biomarkers and 20-year risk of clinically diagnosed Alzheimer's disease#480194
- Blood-based biomarkers and 20-year risk of clinically diagnosed Alzheimer’s disease#424645
- CSF IL-6, GDF-15, GFAP and NfL levels in early Alzheimer disease: a pilot study#202760
- Interaction-based metabolomics identifies serum modifiers of the clinical expression of Alzheimer's disease pathology#417393
Record · ID 867016
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive